Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Visualizing Immune Checkpoint Inhibitors Derived Inflammation in Atherosclerosis

Circulation Research(2024)10.1161/circresaha.124.324260Source: DataRank Database

Visualizing Immune Checkpoint Inhibitors Derived Inflammation in Atherosclerosis is a research paper published in Circulation Research (2024). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 5.09)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Lisa Detering ORCID,Hannah Luehmann ORCID,Junedh Amrute ORCID,Deborah Sultan,Pan Ma ORCID

Live enrichment

PubMed:39328090 PMC:PMC11502258 OpenAlex:https://openalex.org/W4402928739

NIBIB NIH HHS

Grant: P41 EB025815

NHLBI NIH HHS

Grant: R01 HL150891

NHLBI NIH HHS

Grant: R01 HL153436

NHLBI NIH HHS

Grant: R35 HL145212

NHLBI NIH HHS

Grant: R35 HL161185

NHLBI NIH HHS

Grant: R01 HL151685

FWCI

5.09

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11502258/pdf/nihms-2023981.pdf

publisherhttps://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.124.324260

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11502258

journalhttps://doi.org/10.1161/circresaha.124.324260

Fields of Study

Cancer Immunotherapy and BiomarkersImmune cells in cancerAtherosclerosis and Cardiovascular DiseasesAnimalsImmune Checkpoint InhibitorsAtherosclerosisMiceReceptors, CCR2InflammationProgrammed Cell Death 1 ReceptorMice, Knockout, ApoEMacrophagesReceptors, LDLMice, Inbred C57BLInterferon-gammaPlaque, AtheroscleroticDisease Models, AnimalMice, KnockoutRadiopharmaceuticalsPositron-Emission TomographyCopper Radioisotopes

MeSH Terms

Mice, Knockout, ApoEImmune Checkpoint InhibitorsAnimalsCopper RadioisotopesDisease Models, AnimalInflammationInterferon-gammaMacrophagesMice, Inbred C57BLReceptors, LDLMice, KnockoutRadiopharmaceuticalsPositron-Emission TomographyAtherosclerosisMiceReceptors, CCR2Plaque, AtheroscleroticProgrammed Cell Death 1 Receptor

Keywords

ChemokineInflammationImmune systemCCR2Chemokine receptorProinflammatory cytokineCC chemokine receptorsImmunologyMedicineCancer researchBiologyAtherosclerosisMacrophagesPositron-emission TomographyImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being